Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$67,650
+$11,354 QoQ
Shares Held
911
+23.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99.89023051591658.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10976948408342481.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HUNTINGTON NATIONAL BANK holds $14,954,660 across 87 Biotechnology names. BBIO ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,123 | $13,004,582 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
686 | $530,030 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
701 | $139,954 | |
| 4 | INCY |
Incyte Corp
|
1,156 | $108,802 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
2,777 | $90,363 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,595 | $83,354 | |
| 7 | MRNA |
Moderna, Inc.
|
1,496 | $75,996 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
911 | $67,650 |
All Filings in BBIO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,650 | 911 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,296 | 736 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $38,591 | 743 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $15,156 | 351 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,491 | 101 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $27 | 1 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||